Clinical Trial Update: Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a ketamine-midazolam sedative regimen for endoscopic retrograde cholangiopancreatography has completed, involving patients with chola…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangitis
• Choledochal Cyst
• Choledocholithiasis
• Pancreatic Cancer

Drugs mentioned

• Ketamine (ketamine)
• Midazolam (Midazolam)

Snippet

Sponsor: National University of Malaysia | Conditions: Cholangitis, Pancreatic Cancer | Phase 2 | Status: COMPLETED